Histotripsy is a new, FDA-approved, minimally invasive technique that destroys liver tumors using high-frequency ultrasound ...

Rachel Drake, pharmacy technician coordinator, University of Kansas Health System, explains how her team collaborates with ...

A panelist discusses how continuous glucose monitoring (CGM) technology can help overcome therapeutic inertia and key barriers to glycemic control in type 2 diabetes (T2D) patients by providing ...

Researchers study long-term safety of lentiviral gene therapy in primates, finding no evidence of somatic mutations or ...

A national survey of Canadian hematologists reveals gaps and variability in supportive care strategies for older adults with ...

Dan Bloomfield, MD, chief medical officer, Anthos, walks through promising findings demonstrating the efficacy of abelacimab, ...

Cognitive and behavioral techniques can improve physical function and overall well-being in patients with long COVID.

The rate of frailty among patients with multiple sclerosis (MS) ranges from 17% to 66% among ambulatory patients, and frailty ...

Among the most-read coverage for the annual meeting were presentations on the potential and costs of cell and gene therapies, ...

EDO51, an investigational therapy for Duchenne muscular dystrophy (DMD), and is still ongoing in the United Kingdom.

Hans Lee, MD, explores how minimal residual disease (MRD) testing guides treatment decisions for multiple myeloma and highlights the value of patient preferences.

Based on their findings, the researchers suggest the integration of automated measures to identify interventricular septal ...